Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Reset Paris offers a wide range of high-end wellness services including spas, massage, sports and therapy classes. These services are delivered by highly qualified and experienced professionals with a holistic approach. Workshops based on matters like stress-relief, nutrition, focus, memory and sleep are also provided right at the office. The company has recruited a team of freelance professionals and tested their performance with B2B and B2C customers, developed a CRM platform and started collective classes with exceptional feedback. Reset is well-positioned to grow by selling health weeks to companies and increase its visibility through digital marketing.
days to go:
Expired
investment:
£111,430
SuperCarers is an online platform that helps families to find trusted carers living in their local area. SuperCarers do not have the high overhead costs of agencies and therefore enable supercarers to be paid significantly more than the national living wage.
days to go:
Expired
investment:
£1,079,495
Thymia aims to empower clinicians with cutting-edge Neuroscience and AI objectively identify and track mental illness using speech, facial movements and behaviour patterns, enabling personalised, efficient treatment and accurate remote monitoring. They have a large dataset, successful sales, and are raising funds for medical regulation, ADHD expansion, and patent filings.
days to go:
Expired
investment:
£1,126,464
Providing convenient and affordable healthcare to patients either at home or their workplace. Practitioners can visit patients and offer a range of medical treatments including vaccinations, testing, physiotherapy and primary care. Qured have been highly successful in London and are growing at an alarming rate, ready to help the whole of the UK.
days to go:
Expired
investment:
£763,160
Muse is a smart, data-driven financial management application which aims to make financial empowerment a reality for all business owners. The app generates clear snapshots of a company’s finances showing all bank balances, and gives quick access to innovative invoice financing and other smart tools. Muse is live on the App Store and Google Play. Moreover, it has partnered with Prime 5 Finance Limited for invoice finance facility. The funds raised will be used to expand the business, sales channels and give an e-money account card in three currencies.
days to go:
Expired
investment:
£339,920
An online marketplace to buy and sell residential investment properties for those looking to generate an extra income. Vesta has sold 104 properties valued at £22m since launching in 2018. Properties listed contain full documents including tenancy history, due diligence, 360-degree photos and videos, valuations and investment projections. Sellers can list various new or existing sites and buyers can range from sole investors to institutions.
Vesta generates revenue by charging fees to both sellers and buyers. Various payment options are available to sellers and optional fees are charged to those who wish to host viewings for their properties. Buyers are charged a fixed fee after an offer is accepted. Vesta is now raising funds to expand their team, website and property portfolio by increasing brand awareness from marketing campaigns.
days to go:
Expired
investment:
£622,705
